New Alzheimer's Treatment Shows Promise in Trials
Experimental drug slows cognitive decline by 40% in early-stage patients.
Read MoreThe latest medical news, research breakthroughs, and wellness advice.
Experimental drug slows cognitive decline by 40% in early-stage patients.
Read MoreHealth officials monitoring situation but say risk remains low.
Read MoreResearch shows even minimal activity has significant benefits.
Read MoreHospitals struggle to maintain staffing amid growing patient loads.
Read MoreNew recommendations emphasize plant-based proteins.
Read More